BXNDA — BLS Pharmaceuticals Share News
0.000.00%
- AU$211.42m
- AU$209.18m
- AU$29.29m
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 10:52:06
Australia Stock Exchange release from BIOXYNE : Appendix 4C - quarterly
Australia Stock Exchange release from BIOXYNE : Notice of Annual General Meeting/Proxy Form
Australia Stock Exchange release from BIOXYNE : Appendix 4G and Corporate Governance
Australia Stock Exchange release from BIOXYNE : Annual Report to shareholders
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 08:42:49
Australia Stock Exchange release from BIOXYNE : Preliminary Final Report
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 09:25:52
Australia Stock Exchange release from BIOXYNE : Response to ASX Price Query
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 09:14:37
Australia Stock Exchange release from BIOXYNE : Appendix 4C - quarterly
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 19:33:34
Australia Stock Exchange release from BIOXYNE : Appendix 4C Revised
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 12:19:34
Australia Stock Exchange release from BIOXYNE : Appendix 4C - quarterly
Brief: Bioxyne Says Covid-19 To Slow Development In Malaysia, Indonesia
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 09:04:46
Australia Stock Exchange release from BIOXYNE : Market Update
Australia Stock Exchange release from BIOXYNE : Appendix 4D and Half Year Accounts